Discover and read the best of Twitter Threads about #ErisLifesciences
Most recents (1)
#ErisLifesciences Q3 FY22 concall highlights 💊💊
Like & Retweet for better reach !
1. Revenues for the quarter stood at ₹332 Cr (7% growth YoY).
Like & Retweet for better reach !
1. Revenues for the quarter stood at ₹332 Cr (7% growth YoY).
2. EBITDA for the quarter was at ₹122 Cr (13.5% growth YoY). EBITDA margin for the quarter was at 37%. PAT for the quarter was ₹101 Cr (12% growth YoY)
3. The Guwahati facility contributed to 80% of the revenues for the quarter. Operating cash flow to EBITDA stood at 73% for the 9 months.
